<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923997</url>
  </required_header>
  <id_info>
    <org_study_id>LCCC 1948</org_study_id>
    <nct_id>NCT04923997</nct_id>
  </id_info>
  <brief_title>The HealthScore Health Coaching Program</brief_title>
  <acronym>HealthScore</acronym>
  <official_title>The HealthScore Health Coaching Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNC Lineberger Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UNC Lineberger Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: The HealthScore Health Coaching Program aims to deliver 6-months of 1:1 home-based&#xD;
      health coaching to cancer patients receiving treatment and survivors of any diagnosis. This&#xD;
      study hopes to preserve physical function, address unmet physical, nutritional,&#xD;
      psychological, social and other needs.&#xD;
&#xD;
      Procedures: This will be done through individualized health coaching, weekly symptom survey&#xD;
      administration, monthly supportive care questionnaires, and physical assessments at baseline,&#xD;
      3 months and 6 months. Participants: All cancer patients with appointments at UNC Cancer&#xD;
      Hospitals, Duke University Hospital, or other cancer hospitals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Physical Function</measure>
    <time_frame>5 years</time_frame>
    <description>Change in PROMIS Physical Function 8b on a scale of 0-60.5</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cancer</condition>
  <condition>Cancer Metastatic</condition>
  <condition>Survivorship</condition>
  <arm_group>
    <arm_group_label>HealthScore Health Coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants on this arm of the study receive a physical activity tracker, weekly surveys and weekly health coaching for 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HealthScore Health Coaching</intervention_name>
    <description>6 months of integrative health coaching, physical activity goal setting, and surveys.</description>
    <arm_group_label>HealthScore Health Coaching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must have an appointment at a cancer center, including if they are an&#xD;
             inpatient, if they are seen by a clinical service providing care to patients with&#xD;
             cancer or sickle cell disease, and if they are &gt; age 15. They can be receiving active&#xD;
             treatment or in survivorship, with no restrictions based on time since the conclusion&#xD;
             of active treatment. No exclusions will be made based on gender, ethnicity or race.&#xD;
&#xD;
          -  Patient must be willing and able to participate in a 6-month intervention.&#xD;
&#xD;
          -  Patients must be willing and able to provide patient-reported survey responses&#xD;
             electronically or by telephone.&#xD;
&#xD;
          -  Patients must have the ability to use a wearable sensor and view wearable sensor data&#xD;
             at home.&#xD;
&#xD;
          -  Patients must have a working email address and have the ability to check and respond&#xD;
             to email.&#xD;
&#xD;
          -  participation in a research study is allowable by the patient's insurance provider&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who do not read and speak English, as program software has not been&#xD;
             translated into other languages at this time.&#xD;
&#xD;
          -  The patient has concurrent medical or psychiatric conditions that may preclude&#xD;
             participation (i.e. moderate to severe dementia, uncontrolled schizophrenia, or other&#xD;
             conditions that would render them unable to provide informed consent or complete&#xD;
             questionnaires).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brianna Castrogivanni, MS</last_name>
    <phone>919-843-7843</phone>
    <email>brianna_castrogivanni@med.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carly Bailey, MA</last_name>
    <phone>919-445-4255</phone>
    <email>carly_bailey@med.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Wood, MD</last_name>
      <phone>984-974-8349</phone>
      <email>william_wood@med.unc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 7, 2021</study_first_submitted>
  <study_first_submitted_qc>June 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UNC Lineberger Comprehensive Cancer Center</investigator_affiliation>
    <investigator_full_name>William A. Wood, MD</investigator_full_name>
    <investigator_title>Associate Professor of Medicine- Division of Hematology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

